论文部分内容阅读
随着人口老龄化,肺癌在我国发病率逐年上升,而肺癌中非小细胞肺癌(NSCLC)约占80%,多数患者确诊时已超过65岁,大部分患者确诊时已属晚期,失去手术机会。以化疗为主的综合治疗为主要的治疗手段,而老年患者因其进行性基础代谢下降,重要脏器的功能衰退,使得其对各种治疗的耐受性相对降低及治疗毒副反应增加,常常难以耐
With population aging, the incidence of lung cancer in our country increases year by year, and lung cancer in non-small cell lung cancer (NSCLC) accounts for about 80%, the majority of patients diagnosed at the age of 65, most of the patients already diagnosed late, lost the chance of surgery . Chemotherapy-based comprehensive treatment as the main treatment, and elderly patients due to their progressive decline in basic metabolism, the function of important organs decline, making it a variety of treatment is relatively reduced tolerance and treatment of side effects increased, Often difficult to resist